China’s debt interest costs are soaring above U.S. levels and growing faster than any other budget category as Beijing struggles to prop up growth Michigan Senate debate spotlights increase in anti-Muslim rhetoric as midterms race heats up OpenAI publishes solutions to more than 370 outstanding math challenges. The results divide mathematicians but most agree: math will never be the same It’s ‘more likely than not’ humanity loses control: Former AI insiders testify safety fixes may be ‘duct tape that will fall off later’ MAGAnomics is starting to look uncomfortably like Bidenomics Trump reiterates pledge to send $5,000 checks, and hands out smaller payments, as midterm elections loom Respect and laughs as Fury and Joshua face off After months of ‘hell,’ an OpenAI safety researcher suggests way to prevent more rogue AI incidents New Lancashire CEO Kenyon to lead review of club Anthropic CEO Amodei set to meet with Trump after missing state dinner

Maky Zanganeh

Maky Zanganeh

Maky Zanganeh (#3169)

Global Rank #3169
Country Rank #965
Country United States

Maky Zanganeh is listed among the world billionaires tracked by Iconic Billionaires.

  • $ 1 B
  • Biotech
  • United States
  • F
  • 56 Years

Snapshot

Quick Facts

Global Rank #3,169
Country Rank #965
Net Worth $1.1B
Previous Worth $1.1B
Worth Change +$0.0B
Country United States
Industry Biotech
Age 56 Years
Gender F
Worth As Of May 7, 2026
Last Refreshed 05 Sep 2026, 12:00 AM
Residence Miami, Florida
World Billionaires List United States Billionaires Biotech

Profile Data

Personal Stats

Age 55
Source Of Wealth Biotech, Self Made
Self Made Score 6
Residence Miami, Florida
Citizenship United States
Marital Status Married
Children 1
Education Master of Business Administration, Schiller International University; DDS, University of Strasbourg
Net Worth Change +$0.0B +0.0% from previous worth
Previous Net Worth $1.1B
Current Net Worth $1.1B

Worth as of May 7, 2026

About Me

Maky Zanganeh is co-CEO of Summit Therapeutics, a biotech firm with a promising drug candidate to treat lung cancer. She owns just under 5% of the company's stock. Zanganeh, an immigrant from Iran, previously served as chief operating officer of drug firm Pharmacyclics, which was acquired by AbbVie for $21 billion in 2015. Zanganeh first came to the U.S. to work for robotic surgery firm Computer Motion in 2002 after running the company's European operations. Zanganeh runs Summit Therapeutics as co-CEO with Robert (Bob) Duggan, who became a billionaire after investing in and running Pharmacyclics. She and Duggan married in 2024. She trained as a dentist at university in Strasbourg, France and then obtained an MBA while first working at Computer Motion.

Insights

Did You Know?

Zanganeh, who attended high school in Germany and university in France, speaks Persian, German, French and English.

Zanganeh is a cancer survivor; she was diagnosed with breast cancer in 2019 and has since recovered.

Wealth Growth

Net Worth Growth Over Time

Tracking Maky Zanganeh's net worth journey over the years, highlighting key growth phases and financial milestones.

Worth Trend Net Worth Growth
Period Change Worth Movement
Current Net Worth: $1.1B (May 7, 2026)

© Iconic Billionaires